Immediate Impact
1 from Science/Nature 58 standout
Citing Papers
Drug resistance in ovarian cancer: from mechanism to clinical trial
2024 Standout
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study
2023 Standout
Works of Ann Treacy being referenced
Unveiling the epigenomic mechanisms of acquired platinum‐resistance in high‐grade serous ovarian cancer
2023
HER2 Genetic Heterogeneity in Gastric Cancer
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Ann Treacy | 41 | 53 | 96 | 124 | 106 | 34 | 401 | |
| M.-D. Tabone | 41 | 113 | 53 | 179 | 53 | 23 | 449 | |
| Kubilay Ertan | 55 | 42 | 83 | 98 | 86 | 27 | 389 | |
| C Orlandi | 26 | 30 | 38 | 80 | 94 | 29 | 409 | |
| Gabrielle Colleran | 99 | 106 | 54 | 154 | 51 | 39 | 407 | |
| Ivana Kuzmiç Prusac | 44 | 39 | 94 | 130 | 182 | 40 | 373 | |
| Držislav Kalafatić | 43 | 47 | 67 | 119 | 169 | 27 | 388 | |
| Selvan Pather | 188 | 30 | 31 | 71 | 153 | 49 | 455 | |
| G. Crombach | 88 | 26 | 78 | 70 | 111 | 48 | 430 | |
| Mariachiara Bosco | 50 | 41 | 28 | 134 | 262 | 52 | 443 | |
| Mustafa Kır | 64 | 64 | 46 | 82 | 80 | 37 | 430 |
All Works
Loading papers...